Compare Novavax Inc (NVAX) vs Public Storage (PSA) Price & Performance

Novavax (NVAX) trades at $11.01, down 1.87% on the day, with a bullish technical signal from moving averages and strong analyst support (73.9% buy ratings). The company reported revenue of $1.12B in 2025 with a net income of $440.3M, marking a significant turnaround from prior losses, though 2026 projections show a return to negative net income. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivots toward its Matrix-M adjuvant platform through partnerships.

The outlook is mixed: strong valuation ratios (P/E of 3.14, EV/EBITDA of 1.72) and recent earnings beats suggest undervaluation, but persistent cash burn and negative equity pose risks. Investment opportunity lies in partnership-driven growth, while risks include execution challenges and reliance on vaccine demand. Wall Street sentiment remains optimistic despite fundamental volatility.

Public Storage (PSA) trades at $285.52, up 1.25% with a bearish technical signal despite strong profitability metrics. The REIT maintains robust fundamentals with 41.8% net income margin and consistent earnings beats, though valuation ratios appear elevated. Recent developments include the completion of Public Storage Canada acquisition and a $400 million Canadian debt offering, signaling expansion efforts. Cash flow trends show operational stability with $3.19B from operations in 2025, though net cash flow remains negative due to significant investing activity.

The stock presents a mixed outlook with analyst consensus target of $328.33 suggesting 15% upside potential, yet technical indicators and some bearish sentiment create near-term uncertainty. Key risks include REIT sector sensitivity to interest rates and competitive pressures, while the 4.05% dividend yield provides income support. Institutional activity shows mixed positioning with recent large purchases offset by selective reductions.